중동 및 아프리카 히알루론산 시장 – 2030년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

중동 및 아프리카 히알루론산 시장 – 2030년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Jan 2023
  • MEA
  • 350 Pages
  • 테이블 수: 300
  • 그림 수: 39

Middle East And Africa Hyaluronic Acid Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
2023 –2030
Diagram 시장 규모(기준 연도)
USD 263.81 Million
Diagram 시장 규모(예측 연도)
USD 409.69 Million
Diagram 연평균 성장률
%
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>중동 및 아프리카 히알루론산 시장 - 등급(화장품 등급 및 제약 등급), 유형(가수분해 히알루론산, 아세틸화 히알루론산 나트륨 및 히알루론산 나트륨), 응용 분야(미용, 골관절염, 제약 API, 화장품 , 안과 및 기타), 최종 사용자(메디컬 스파 및 뷰티 센터, 피부과 병원 및 성형 수술 센터), 유통 채널(직접 입찰 및 소매 판매) 산업 동향 및 2030년 예측.

히알루론산 시장

중동 및 아프리카 히알루론산 시장 분석 및 통찰력

히알루론산은 주로 뷰티 및 스킨 케어 제품에 사용됩니다. 상처에 대한 빠른 회복을 제공하고, 얼굴 주름, 주름살, 피부 노화를 줄이며, 상처와 화상을 치료합니다. 피부 톤을 밝게 하는 비타민 C가 들어 있습니다. 히알루론산이 함유된 뷰티 제품은 보습제, 크림, 스킨 토너, 세럼 등의 형태로 바르면 피부에 영양을 공급합니다.

히알루론산 시장

히알루론산 시장

Data Bridge Market Research에 따르면 중동 및 아프리카 히알루론산 시장은 2023년부터 2030년까지의 예측 기간 동안 5.7%의 CAGR로 성장할 것으로 분석되며, 2022년 2억 6,381만 달러에서 2030년까지 4억 969만 달러에 도달할 것으로 예상됩니다.

보고서 메트릭

세부

예측 기간

2023년부터 2030년까지

기준 연도

2022

역사적 연도

2021 (2020-2016까지 사용자 정의 가능)

양적 단위

수익 (단위: USD 백만)

다루는 세그먼트

등급(화장품 등급 및 제약 등급), 유형(가수분해 히알루론산, 아세틸화 히알루론산 나트륨, 히알루론산 나트륨), 응용 분야(미용, 골관절염, 제약 API, 화장품, 안과 및 기타), 최종 사용자(메디컬 스파 및 뷰티 센터, 피부과 병원, 성형 수술 센터), 유통 채널(직접 입찰 및 소매 판매)별.

적용 국가

남아프리카공화국, 사우디아라비아, UAE, 이집트, 이스라엘, 그리고 나머지 중동과 아프리카 국가.

시장 참여자 포함

Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Oceania International LLC가 소유한 Stanford Chemicals, Bioiberica SAU, GENESIS pharmacy services, Brickell Men's Products 등

시장 정의

히알루론산(HA)은 히알루론산이라고도 불리며, 결합 조직, 상피 조직 및 신경 조직 전체에 널리 분포된 음이온성, 비황산화 글리코사미노글리칸입니다. 관절 연골의 필수 성분인 히알루론산은 연골의 각 세포를 코트(연골세포)처럼 둘러싸고 있습니다. 연골의 견고함은 이러한 응집체가 물을 섭취하기 때문입니다(압축에 대한 저항성). 연골의 히알루론산 분자량(크기)은 나이가 들면서 감소하지만 양은 증가합니다. 인체에는 자연적으로 HA가 포함되어 있습니다. HA의 가장 많은 양은 관절과 눈에서 발견됩니다. 이 화학 물질은 윤기 있고 촉촉한 피부를 유지하는 능력이 있습니다. 그 결과, 많은 성형외과 의사가 피부의 노화 징후를 지연시키는 주사제로 사용합니다.

최소 침습적 시술의 증가와 전 세계 제약 및 화장품에서 히알루론산에 대한 인식과 수요가 증가하는 것은 예측 기간 동안 시장 성장을 이끄는 주요 요인입니다. 연구의 질이 극적으로 상승하고 연구 기회가 늘어나는 것은 시장 참여자들이 취한 다양한 전략적 이니셔티브 때문입니다. 그들은 수년에 걸쳐 제품 출시, 협업, 합병, 인수 등과 같은 이니셔티브를 취하고 있으며 시장에서 더 많은 기회를 주도하고 창출할 것으로 예상됩니다.

중동 및 아프리카 히알루론산 시장 동향

이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.

운전자

  • 미용 주사 또는 피부 필러에 대한 인식 증가

히알루론산 기반 피부 필러는 덜 침습적인 미용 과정입니다. 피부과 문제는 전 세계적으로 흔합니다. 피부 관련 문제를 치료하고 피부 주름을 회복하는 제품을 이해하는 것이 주요 관심사가 되었습니다. 히알루론산 주사제의 적절한 사용에 대한 인식을 높이기 위해 다양한 프로그램이 시작되었습니다.

의식이 높아지면 소비자는 여드름과 주름에 대한 올바른 치료법을 선택하고 올바른 원인에 따라 올바른 제품(보톡스 주사, 피부 필러)을 선택할 수 있습니다. 이는 매출 증가, 제품 포트폴리오 증가, 제품 라인 확장으로 이어질 것입니다. 이 요인은 시장 성장을 촉진할 것으로 예상됩니다.

  • 침습적 히알루론산 기반 피부 필러 사용

히알루론산 기반 피부 필러는 전 세계적으로 빠르게 증가하고 있는 덜 침습적인 미용 시술입니다. 이는 얼굴 개선, 얼굴 볼륨 회복 및 미적 개선을 위한 인기 있는 미용 시술입니다.

이들은 매우 다재다능하며 미세한 선과 주름에 사용됩니다. 또한 여드름, 주름, 흉터를 치료하고 입술, 볼, 턱을 확대하는 데에도 사용됩니다. 노인 인구의 증가로 인해 비침습적 수술 프로토콜의 필요성이 높아졌습니다.

히알루론산 기반 피부 필러를 도입하면 정상적인 수술을 선택할 가능성이 줄어듭니다. 치료 비용이 최소화되고 이 요인이 시장 성장을 촉진할 것입니다.

제약

  • 허가받지 않은 또는 대체 피부 필러의 가용성으로 시장 방해

히알루론산 기반 피부 필러의 미용적 용도가 널리 보급됨에 따라, 이러한 제품의 몇 가지 제한 요소로 인해 향후 몇 년 동안 중동 및 아프리카 시장 성장이 방해받을 것으로 예상됩니다.

높은 효능, 환자 만족도, 동적 주름 개선에 대한 사용 등으로 인해 보툴리눔 독소 유형의 피부 필러가 전 세계적으로 비수술적 미용 시술을 선도하고 있습니다.

또한 칼슘하이드록시아파타이트(CaHA)와 폴리-L-락틱산과 같은 다른 생분해성 필러도 수명이 긴 임플란트 대체 필러로 인기를 얻고 있습니다.

의사들은 저렴한 불법 제품을 사용하는 것을 꺼리는 것으로 관찰되었는데, 이는 관련된 위험 때문입니다. 반대로, 피부 필러 부문에서 불법 제품을 사용할 수 있게 되면 특히 히알루론산 부문에서 가격 경쟁이 치열해질 것입니다. 단위당 높은 가격을 제공하는 대형 회사는 여러 제품 번들을 제공하고 다양한 제품 부문에서 제품을 판매함으로써 경쟁할 수 있습니다.

히알루론산 피부 필러의 가격이 낮아진 것을 보상하기 위해 입자 및 폴리머 제조업체는 제품을 홍보해야 합니다. 이 세그먼트에서 제공되는 제품은 다양합니다. 제조업체는 원가보다는 피부 필러에 사용된 재료 강도에 더 집중할 것입니다.

기회

  • 히알루론산 제품의 새로운 기술과 개발

첨단 혁신 기술은 필요한 곳마다 피부와 신체의 다른 부위에 대한 미용적 치료를 개선했으며, 스킨케어 산업은 가장 빠르게 변화하는 산업 중 하나입니다. 활성 성분, 성분 기반 스킨케어 및 뷰티 공간을 갖춘 국내 브랜드는 투자가 증가하고 있으며, 소비자는 적극적으로 참여하고 있습니다. 첨단 혁신 기술과 히알루론산 기반 제품의 개발은 시장에서 히알루론산에 대한 수요를 증가시킵니다.

히알루론산 피부 제품은 얼굴의 결점을 교정하고, 볼륨을 보상하며, 얼굴의 특정 부위를 강조하는 히알루론산을 기반으로 합니다. 피부 제품의 발전은 얼굴 특징을 향상, 회복 및 정의하는 효과적인 방법을 제공합니다. 히알루론산 기반 제품의 발전과 피부 필러 시술은 고객을 화장품으로 끌어들입니다. 따라서 히알루론산 피부 제품의 기술적 발전이 시장 성장의 기회로 작용할 것으로 예상됩니다.

도전 과제

  • 제품 리콜 확대

히알루론산 기반 제품의 리콜은 시장 성장에 큰 영향을 미쳤습니다. 규제 당국은 건강 및 안전 문제로 인해 미용 및 화장품 제품을 리콜합니다. 모든 국가에는 의료 관련 제품의 규제를 모니터링하는 책임이 있는 자체 규제 당국이 있습니다.

환자 건강 안전 문제(내용의 부정확성이나 성분 오류 등)로 인해 기업이나 규제 당국이 제품을 리콜하는 경우가 있는데, 이는 시장 성장에 어려움을 주는 주요 문제 중 일부입니다. 환자의 안전과 건강은 제품을 시장에 출시하는 모든 시장에서 가장 중요한 기준이기 때문입니다.

최근 개발 사항

  • 2022년 2월, Allergan(AbbVie Inc.의 자회사)은 21세 이상 성인의 눈 아래 움푹 들어간 부위를 개선하기 위한 JUVÉDERM VOLBELLA XC의 FDA 승인을 발표했습니다. 이를 통해 회사는 미국 시장에서 미용 제품 포트폴리오를 확장할 수 있었습니다.
  • 체코에 본사를 둔 유명 히알루론산 제조사인 콘티프로는 2021년 2월 피부 개선 및 항노화, 여드름 치료 제품인 하이레틴(HyRetin) 출시를 발표했습니다.

중동 및 아프리카 히알루론산 시장 범위

중동 및 아프리카 히알루론산 시장은 등급, 유형, 응용 분야, 최종 사용자 및 유통 채널을 기준으로 5개의 주요 세그먼트로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 분야를 식별하기 위한 전략적 결정을 내릴 수 있는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.

등급

  • 화장품 등급
  • 제약 등급

등급을 기준으로 시장은 화장품 등급과 제약 등급으로 구분됩니다.

유형

  • 가수분해 히알루론산
  • 아세틸화 히알루론산나트륨
  • 히알루론산나트륨

시장은 유형에 따라 가수분해 히알루론산, 아세틸화 히알루론산 나트륨, 히알루론산 나트륨으로 구분됩니다.

애플리케이션

  • 미학
  • 골관절염
  • 제약 API
  • 화장품
  • 안과학
  • 기타

시장은 응용 분야별로 미용, 골관절염, 제약 API, 화장품, 안과 및 기타 분야로 구분됩니다.

최종 사용자

  • 제약 산업
  • 피부과 병원
  • 성형외과 센터
  • 기타

최종 사용자를 기준으로 시장은 제약 산업, 피부과 병원, 성형외과 센터 등으로 구분됩니다.

유통 채널

  • 직접 입찰
  • 소매 판매

유통 채널을 기준으로 시장은 직접 입찰과 소매 판매로 구분됩니다.

중동 및 아프리카 히알루론산 시장 지역 분석/통찰력   

중동 및 아프리카 히알루론산 시장을 분석하고, 위에 언급된 대로 국가, 등급, 유형, 응용 분야, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

이 시장 보고서에서 다루는 국가는 남아프리카공화국, 사우디아라비아, UAE, 이집트, 이스라엘, 그리고 나머지 중동 및 아프리카 국가입니다.

  • 2023년에 남아프리카는 시장 점유율과 수익 면에서 중동 및 아프리카 히알루론산 시장을 지배하고 있으며 예측 기간 동안에도 지배력을 계속 유지할 것입니다. 이는 제품 승인 증가 때문입니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 중동 및 아프리카 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 중동 및 아프리카 히알루론산 시장 점유율 분석

중동 및 아프리카 히알루론산 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 중동 및 아프리카 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

중동 및 아프리카 히알루론산 시장의 주요 기업으로는 Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Oceania International LLC가 소유한 Stanford Chemicals, Bioiberica SAU, GENESIS pharmacy services, Brickell Men's Products 등이 있습니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 GRADE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES

4.4 INDUSTRY INSIGHTS

5 REGULATORY FRAMEWORK

5.1 EGULATORY SCENARIO IN THE U.S.

5.2 REGULATORY SCENARIO IN EUROPE

5.3 REGULATORY SCENARIO IN CHINA

5.4 REGULATORY SCENARIO IN AUSTRALIA

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS

6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS

6.1.3 RISE IN PRODUCT APPROVALS

6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES

6.2 RESTRAINTS

6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET

6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES

6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION

6.3 OPPORTUNITIES

6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS

6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS

6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.4 INCREASING RESEARCH AND DEVELOPMENT

6.4 CHALLENGES

6.4.1 ESCALATING PRODUCT RECALL

6.4.2 LACK OF EXPERTISE

7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE

7.1 OVERVIEW

7.2 COSMETIC GRADE

7.2.1 GENDER

7.2.1.1 FEMALE PRODUCTS

7.2.1.2 MEN’S PRODUCT

7.2.2 PRODUCT TYPE

7.2.2.1 SKIN CARE

7.2.2.2 MAKEUP

7.2.2.3 CLEANSING

7.2.2.4 HAIR CARE

7.2.2.5 OTHERS

7.2.3 PROCEDURE

7.2.3.1 WRINKLE REMOVAL

7.2.3.2 SKIN SMOOTHENING

7.2.3.3 FACE LIFT

7.2.3.4 LIP AUGMENTATION

7.2.3.5 CHIN AUGMENTATION

7.2.3.6 FAT INJECTION

7.2.3.7 FACE LINE CORRECTION

7.2.3.8 ACNE SCAR TREATMENT

7.2.3.9 LIP PLUM

7.2.3.10 EAR LOBE REJUVENATION

7.2.3.11 LIPOATROPHY TREATMENT

7.2.3.12 OTHERS

7.3 PHARMACEUTICAL GRADE

7.3.1 TYPE

7.3.1.1 MEDICAL GRADE HYALURONIC ACID

7.3.1.2 INJECTION GRADE HYALURONIC ACID

7.3.2 PRODUCT TYPE

7.3.2.1 TOPICAL PREPARATIONS

7.3.2.2 INTRA-ARTICULAR INJECTION

7.3.2.2.1 PREFILLED INJECTIONS

7.3.2.2.2 VIAL

7.3.2.3 EYE DROPS

7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS

7.3.2.5 OTHERS

8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE

8.1 OVERVIEW

8.2 SODIUM HYALURONATE

8.2.1 MOLECULAR WEIGHT

8.2.1.1 HIGH MOLECULAR WEIGHT

8.2.1.2 LOW MOLECULAR WEIGHT

8.2.1.3 MEDIUM MOLECULAR WEIGHT

8.2.2 BY TYPE

8.2.2.1 COSMETIC GRADE

8.2.2.1.1 GENDER

8.2.2.1.1.1 FEMALE PRODUCTS

8.2.2.1.1.2 MEN'S PRODUCT

8.2.2.1.2 PRODUCT TYPE

8.2.2.1.2.1 SKIN CARE

8.2.2.1.2.2 MAKEUP

8.2.2.1.2.3 CLEANSING

8.2.2.1.2.4 HAIR CARE

8.2.2.1.2.5 OTHERS

8.2.2.2 PHARMACEUTICAL GRADE

8.2.2.2.1 TYPE

8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.2.2.2.2 PRODUCT TYPE

8.2.2.2.2.1 TOPICAL PREPARATIONS

8.2.2.2.2.2 INTRA-ARTICULAR INJECTION

8.2.2.2.2.2.1 PREFILLED INJECTIONS

8.2.2.2.2.2.2 VIAL

8.2.2.2.2.3 EYE DROPS

8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.2.2.2.2.5 OTHERS

8.3 HYDROLYZED HYALURONIC ACID

8.3.1 MOLECULAR WEIGHT

8.3.1.1 HIGH MOLECULAR WEIGHT

8.3.1.2 LOW MOLECULAR WEIGHT

8.3.1.3 MEDIUM MOLECULAR WEIGHT

8.3.2 BY TYPE

8.3.2.1 COSMETIC GRADE

8.3.2.1.1 GENDER

8.3.2.1.1.1 FEMALE PRODUCTS

8.3.2.1.1.2 MEN'S PRODUCT

8.3.2.1.2 PRODUCT TYPE

8.3.2.1.2.1 SKIN CARE

8.3.2.1.2.2 MAKEUP

8.3.2.1.2.3 CLEANSING

8.3.2.1.2.4 HAIR CARE

8.3.2.1.2.5 OTHERS

8.3.2.2 PHARMACEUTICAL GRADE

8.3.2.2.1 TYPE

8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.3.2.2.2 PRODUCT TYPE

8.3.2.2.2.1 TOPICAL PREPARATIONS

8.3.2.2.2.2 INTRA-ARTICULAR INJECTION

8.3.2.2.2.2.1 PREFILLED INJECTIONS

8.3.2.2.2.2.2 VIAL

8.3.2.2.2.3 EYE DROPS

8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.3.2.2.2.5 OTHERS

8.4 SODIUM ACETYLATED HYALURONIC ACID

8.4.1 MOLECULAR WEIGHT

8.4.1.1 HIGH MOLECULAR WEIGHT

8.4.1.2 LOW MOLECULAR WEIGHT

8.4.1.3 MEDIUM MOLECULAR WEIGHT

8.4.2 BY TYPE

8.4.2.1 COSMETIC GRADE

8.4.2.1.1 GENDER

8.4.2.1.1.1 FEMALE PRODUCTS

8.4.2.1.1.2 MEN'S PRODUCT

8.4.2.1.2 PRODUCT TYPE

8.4.2.1.2.1 SKIN CARE

8.4.2.1.2.2 MAKEUP

8.4.2.1.2.3 CLEANSING

8.4.2.1.2.4 HAIR CARE

8.4.2.1.2.5 OTHERS

8.4.2.2 PHARMACEUTICAL GRADE

8.4.2.2.1 TYPE

8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.4.2.2.2 PRODUCT TYPE

8.4.2.2.2.1 TOPICAL PREPARATIONS

8.4.2.2.2.2 INTRA-ARTICULAR INJECTION

8.4.2.2.2.2.1 PREFILLED INJECTIONS

8.4.2.2.2.2.2 VIAL

8.4.2.2.2.3 EYE DROPS

8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.4.2.2.2.5 OTHERS

9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 AESTHETICS

9.3 OSTEOARTHRITIS

9.4 COSMETICS

9.5 OPHTHALMOLOGY

9.6 PHARMACEUTICAL API

9.7 OTHERS

10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER

10.1 OVERVIEW

10.2 DERMATOLOGY CLINICS

10.3 COSMETIC SURGERY CENTERS

10.4 MEDICAL SPAS AND BEAUTY CENTERS

10.5 OTHERS

11 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL PHARMACY

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY REGION

12.1 MIDDLE EAST AND AFRICA

12.1.1 SOUTH AFRICA

12.1.2 SAUDI ARABIA

12.1.3 U.A.E.

12.1.4 EGYPT

12.1.5 ISRAEL

12.1.6 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 FIDIA FARMACEUTICI S.P.A. (2022)

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 ABBVIE INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 GALDERMA

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 LG CHEM (2022)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ABBOTT (2022)

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ANIKA THERAPEUTICS, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 COMPANY SHARE ANALYSIS

15.7.4 PRODUCT PORTFOLIO

15.7.5 RECENT DEVELOPMENTS

15.8 BIOSCIENCE GMBH

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 BIOXIS PHARMACEUTICALS

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 BIOIBERICA S.A.U

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 BOHUS BIOTECH AB

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BRICKELL MEN'S PRODUCTS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CONTIPRO A.S.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 FILLMED

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 GENESIS

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 HUONS

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 KEWPIE CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 LIFECORE BIOMEDICAL, INC.(2022)

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 PROLLENIUM MEDICAL TECHNOLOGIES

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 RIVER PHARMA S.R.L.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENTS

15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENTS

15.24 SYMATESE

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 TEOXANE

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 VIRCHOW BIOTECH

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

표 목록

TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:

TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME

TABLE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 58 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 59 MIDDLE EAST AND AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 62 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 63 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 65 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 66 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 67 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 68 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 69 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 70 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 71 MIDDLE EAST AND AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 73 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 74 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 78 MIDDLE EAST AND AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 79 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 82 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 85 MIDDLE EAST AND AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 86 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 88 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 89 MIDDLE EAST AND AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 91 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 92 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 93 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 94 MIDDLE EAST AND AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 95 SOUTH AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 96 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 97 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 99 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 100 SOUTH AFRICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 101 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 102 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 103 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 104 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 106 SOUTH AFRICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 107 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 109 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 110 SOUTH AFRICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 111 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 112 SOUTH AFRICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 114 SOUTH AFRICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 116 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 119 SOUTH AFRICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 120 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 121 SOUTH AFRICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 SOUTH AFRICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 125 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 126 SOUTH AFRICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 127 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 128 SOUTH AFRICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 129 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 130 SOUTH AFRICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 SOUTH AFRICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 SOUTH AFRICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 133 SOUTH AFRICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 134 SOUTH AFRICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 135 SOUTH AFRICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 136 SAUDI ARABIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 137 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 138 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 140 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 141 SAUDI ARABIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 142 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 144 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 145 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 147 SAUDI ARABIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 148 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 150 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 151 SAUDI ARABIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 152 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 153 SAUDI ARABIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 154 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 155 SAUDI ARABIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 156 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 157 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 158 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 159 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 160 SAUDI ARABIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 162 SAUDI ARABIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 163 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 SAUDI ARABIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 165 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 166 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 167 SAUDI ARABIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 168 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 169 SAUDI ARABIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 170 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 171 SAUDI ARABIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 172 SAUDI ARABIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 173 SAUDI ARABIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 SAUDI ARABIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 175 SAUDI ARABIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 176 SAUDI ARABIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 177 U.A.E. HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 178 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 179 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 180 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 181 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 182 U.A.E. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 183 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 184 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 185 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 186 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 187 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 188 U.A.E. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 189 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 191 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 192 U.A.E. HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 194 U.A.E. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 195 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 196 U.A.E. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 198 U.A.E. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 200 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 201 U.A.E. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 202 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 203 U.A.E. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 205 U.A.E. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 U.A.E. INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 208 U.A.E. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 210 U.A.E. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 212 U.A.E. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 213 U.A.E. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 U.A.E. HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 215 U.A.E. HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 216 U.A.E. HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 217 U.A.E. RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 218 EGYPT HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 219 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 220 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 221 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 222 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 223 EGYPT COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 224 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 225 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 226 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 227 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 228 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 229 EGYPT PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 230 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 231 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 232 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 233 EGYPT HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 234 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 235 EGYPT SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 236 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 237 EGYPT COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 238 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 239 EGYPT PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 240 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 241 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 242 EGYPT HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 243 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 244 EGYPT COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 245 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 246 EGYPT PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 247 EGYPT INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 248 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 249 EGYPT SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 250 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 251 EGYPT COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 253 EGYPT PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 254 EGYPT INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 255 EGYPT HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 256 EGYPT HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 257 EGYPT HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 258 EGYPT RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 259 ISRAEL HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 260 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 261 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 263 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 264 ISRAEL COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 265 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 266 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 267 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 268 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 269 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 270 ISRAEL PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 271 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 272 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 273 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 274 ISRAEL HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 275 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 276 ISRAEL SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 277 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 278 ISRAEL COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 279 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 280 ISRAEL PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 282 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 283 ISRAEL HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 284 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 285 ISRAEL COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 286 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 ISRAEL PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 288 ISRAEL INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 289 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 290 ISRAEL SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 291 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 292 ISRAEL COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 293 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 294 ISRAEL PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 295 ISRAEL INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 296 ISRAEL HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 ISRAEL HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 298 ISRAEL HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 299 ISRAEL RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 300 REST OF MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

그림 목록

FIGURE 1 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: DBMR POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: END USER COVERAGE GRID

FIGURE 10 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA HYALURONIC ACID MARKET

FIGURE 14 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2022

FIGURE 15 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)

FIGURE 16 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)

FIGURE 17 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE

FIGURE 18 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2022

FIGURE 19 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)

FIGURE 20 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 21 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2022

FIGURE 23 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 24 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2022

FIGURE 27 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: SNAPSHOT (2022)

FIGURE 35 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022)

FIGURE 36 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET: GRADE (2023-2030)

FIGURE 39 MIDDLE EAST & AFRICA HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Middle East and Africa Hyaluronic Acid Market is projected to grow at a CAGR of 5.7% during the forecast period by 2030.
The future market value of the Middle East and Africa Hyaluronic Acid Market is expected to reach USD 409.69 million by 2030.
The major players in the Middle East and Africa Hyaluronic Acid Market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., etc.
The countries covered in the Middle East and Africa Hyaluronic Acid Market are South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.